Average Co-Inventor Count = 6.37
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (8 from 3,684 patents)
2. Gilead Sciences, Inc. (5 from 923 patents)
3. Kronos Bio, Inc. (2 from 10 patents)
4. Astrazeneca Ab (1 from 1,500 patents)
5. Britsol-myers Squibb Company (1 from 3 patents)
17 patents:
1. 12202849 - Crystalline forms of tenofovir alafenamide
2. 12152037 - Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor
3. 11613553 - Methods of preparing 1'-cyano nucleosides
4. 11440928 - Crystalline forms of tenofovir alafenamide
5. 11339168 - Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors
6. 10407438 - Crystalline forms of darunavir
7. 10287307 - Crystalline forms of tenofovir alafenamide
8. 9453039 - Crystal structures of SGLT2 inhibitors and processes for preparing same
9. 8501698 - Crystal structures of SGLT2 inhibitors and processes for preparing same
10. 7968718 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
11. 7932379 - Methods of producing C-aryl glucoside SGLT2 inhibitors
12. 7919598 - Crystal structures of SGLT2 inhibitors and processes for preparing same
13. 7820820 - Method of preparation of azaindole derivatives
14. 7671199 - Process for the preparation of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2, 1-F][1,2,4]triazin-6-yloxy]-1-methylethyl ester
15. 7601715 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein